167 related articles for article (PubMed ID: 38254070)
21. [The Latest Research Progress on Myelodysplastic Syndrome Patient-derived Mesenchymal Stem Cell--Review].
Li F; He HP; Zhang LH; Ling XS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1286-1290. PubMed ID: 35981400
[TBL] [Abstract][Full Text] [Related]
22. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
23. Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitro.
Calkoen FG; Vervat C; van Pel M; de Haas V; Vijfhuizen LS; Eising E; Kroes WG; 't Hoen PA; van den Heuvel-Eibrink MM; Egeler RM; van Tol MJ; Ball LM
Stem Cell Res; 2015 Mar; 14(2):198-210. PubMed ID: 25679997
[TBL] [Abstract][Full Text] [Related]
24. The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes.
Zhao Z; Wang Z; Li Q; Li W; You Y; Zou P
PLoS One; 2012; 7(9):e45675. PubMed ID: 23029178
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
Weickert MT; Hecker JS; Buck MC; Schreck C; Rivière J; Schiemann M; Schallmoser K; Bassermann F; Strunk D; Oostendorp RAJ; Götze KS
Sci Rep; 2021 Mar; 11(1):5944. PubMed ID: 33723276
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of Proliferation Characters of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Myelodysplastic Syndrome].
Pang YB; Zhang MJ; Li SR; Zhang J; Zhao XL; Zhang JB; Wang JY; Fang GT; Zhang R; Fan LX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1224-1230. PubMed ID: 34362506
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.
Fei CM; Guo J; Zhao YS; Zhao SD; Zhen QQ; Shi L; Li X; Chang CK
J Transl Med; 2018 Aug; 16(1):234. PubMed ID: 30143008
[TBL] [Abstract][Full Text] [Related]
28. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
[TBL] [Abstract][Full Text] [Related]
29. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
[TBL] [Abstract][Full Text] [Related]
30. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
[TBL] [Abstract][Full Text] [Related]
31. Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes.
Xiong H; Yang XY; Han J; Wang Q; Zou ZL
Braz J Med Biol Res; 2015 Mar; 48(3):207-13. PubMed ID: 25608238
[TBL] [Abstract][Full Text] [Related]
32. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
Fei C; Zhao Y; Guo J; Gu S; Li X; Chang C
Eur J Haematol; 2014 Dec; 93(6):476-86. PubMed ID: 24889123
[TBL] [Abstract][Full Text] [Related]
33. [Expression of SDF-1 gene in bone marrow mesenchymal stem cells of patients with myelodysplastic syndrome].
Zhang YZ; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):281-4. PubMed ID: 16638197
[TBL] [Abstract][Full Text] [Related]
34. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
36. Identification of latent core genes and pathways associated with myelodysplastic syndromes based on integrated bioinformatics analysis.
Zhu Y; Wu L
Hematology; 2020 Dec; 25(1):299-308. PubMed ID: 32772642
[No Abstract] [Full Text] [Related]
37. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
38. HOX gene analysis of endothelial cell differentiation in human bone marrow-derived mesenchymal stem cells.
Chung N; Jee BK; Chae SW; Jeon YW; Lee KH; Rha HK
Mol Biol Rep; 2009 Feb; 36(2):227-35. PubMed ID: 17972163
[TBL] [Abstract][Full Text] [Related]
39. Discrepancy in transcriptomic profiling between CD34 + stem cells and primary bone marrow cells in myelodysplastic neoplasm.
Ribeiro Junior HL; Gonçalves PG; Moreno DA; Goes JVC; de Oliveira RTG; Montefusco-Pereira CV; Komoto TT; Pinheiro RF
Leuk Res; 2023 Jun; 129():107071. PubMed ID: 37004280
[TBL] [Abstract][Full Text] [Related]
40. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
Elife; 2023 Jan; 12():. PubMed ID: 36629404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
